No association between migraine and breast cancer risk
the ONA take:
According to a new study published in the Journal of the National Cancer Institute, researchers at Harvard University Medical School in Boston, Massachusetts, have found that there is no associated between migraines and risk of breast cancer.
For the studies, researchers analyzed four other studies that included over 100,000 women actually found that migraines may decrease the risk of breast cancer, but researchers note that this finding may be due to study design rather than a real association.
The theory that there was a link between migraines and risk of breast cancer comes up from the notion that both arise from increased sex hormone levels. When the research team analyzed the levels of sex hormones in about 2,000 premenopausal women who experience migraines, the researchers found no link between the two.
According to the Migraine Research Foundation, approximately 18% of American women and 6% of American men experience migraines. A migraine is a severe headache that is often accompanied by sensitivity to light and sound, nausea, visual disturbances, and vomiting. A migraine can last anywhere between 4 hour and 3 days.
There is no associated between migraines and risk of breast cancer.
Sign Up for Free e-newsletters
- Scalp Cooling With Dignicap May Reduce Alopecia During Chemotherapy for Breast Cancer
- Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
- Dedicated End-of-Life Education Program Improves Nurses' Care, Patient and Family Satisfaction
- Reflexology, Aromatherapy May Reduce Pain, Anxiety of Brachytherapy for Cervical Cancer
- Oncology Extended Care Clinic Reduced Urgent Cancer-Related ED Visits
- Hair Dyes and Cancer Risk (Fact Sheet)
- Taste Changes After Hematopoietic Stem Cell Transplant Affect QOL in Blood Cancers
- Hope, Optimism Reduce Psychological Distress in Advanced Cancer
- Mitomycin Extravasation Protocol
- Accurate Understanding of Capacity May Improve Workflow, Efficiency in Infusion Suite
- Nursing Practice Change Improved Chemo Administration, But Old Habits Die Hard
- Simple Adjustment Key to Paclitaxel Infusion Protocol That Reduced Hypersensitivity Reactions
- Online Program Aims to Assist With Clinical Trial Enrollment for Hematologic Cancers
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|